You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Colorcon
McKinsey
Baxter
Dow

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

CETAMIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Cetamide patents expire, and what generic alternatives are available?

Cetamide is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in CETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Cetamide

A generic version of CETAMIDE was approved as sulfacetamide sodium by SANDOZ INC on October 18th, 1988.

  Start Trial

Summary for CETAMIDE
Drug patent expirations by year for CETAMIDE
Synonyms for CETAMIDE
2-Carbamoylphenol
2-Carboxamidophenol
2-Hydroxy-benzamide
2-Hydroxybenzamide
2-HYDROXYBENZAMIDE (SEE ALSO:N-HYDROXYBENZAMIDE (CAS 495-18-1))
2-oxidanylbenzamide
4-10-00-00169 (Beilstein Handbook Reference)
65-45-2
91096-EP2380872A1
A835120
AB00052089_12
AB1004776
Acket
ACMC-209nqv
Afko-Sal
AH-034/32461056
AI3-03454
AK-81394
AKOS000120983
Algamon
Algiamida
Allevin
Amid kyseliny salicylove
Amid kyseliny salicylove [Czech]
Amid-Sal
Amidosal
Anamid
Andasol
ANW-35045
BBL016007
BDBM50056900
Benesal (VAN)
Benzamide, 2-hydroxy-
Benzamide, o-hydroxy-
Benzoic acid, 2-hydroxy-, amide
BENZOIC ACID,2-HYDROXY,AMIDE SALICYLAMIDE
BR-81394
BRD-K81130846-001-02-6
BRD-K81130846-001-12-5
BRN 0742439
BSPBio_001948
CAS-65-45-2
CCG-39250
CCRIS 6045
CHEBI:32114
CHEMBL27577
component of Tolagesic (Salt/Mix)
CS-7630
CTK2F3950
D01811
DB08797
dihydroxybenzalamine
DivK1c_000858
Dolomide
Dropsprin
DS-16216
DSSTox_CID_1726
DSSTox_GSID_21726
DSSTox_RID_76295
DTXSID3021726
EC 200-609-3
Eggosalil
EINECS 200-609-3
EM8BM710ZC
EU-0000058
Flarpirina
FT-0659360
H.P. 34
HMS1920P14
HMS2092G15
HMS2232E07
HMS502K20
HSDB 227
HY-B0811
Hydrochlorothiazide Related Compound
hydroxy benzamide
IDI1_000858
InChI=1/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10
J-509663
KBio1_000858
KBio2_001426
KBio2_003994
KBio2_006562
KBio3_001448
KBioGR_001017
KBioSS_001426
KS-00000H1J
KSC353S5B
Liquiprin
LS-1556
M-6078
MCULE-5482995635
MFCD00007978
MLS000069486
Morsarinas
NCGC00091414-01
NCGC00091414-02
NCGC00091414-03
NCGC00091414-04
NCGC00091414-05
NCGC00091414-07
NCGC00256376-01
NCGC00259493-01
NCIOpen2_001127
NINDS_000858
Novecyl
NSC 3115
NSC-3115
NSC-757318
NSC3115
NSC757318
o-Hydroxybenzamide
OHB
Opera_ID_1684
Oprea1_069894
Oramid
Panithal
Pharmakon1600-01500532
PubChem10992
Q2496906
Raspberin
RTR-022279
S0006
s6404
Salamid
Salamide
Saliamid
Saliamin
Salicilamida
Salicilamida [INN-Spanish]
Salicilamide
Salicilamide [DCIT]
Salicilamide [Italian]
Salicim
Saliclamide,(S)
Salicylamid
salicylamide
Salicylamide (JAN/USP/INN)
Salicylamide (TN)
Salicylamide [INN:BAN:JAN]
Salicylamide [USP:INN:BAN:JAN]
Salicylamide, 99%
Salicylamide, Pharmaceutical Secondary Standard; Certified Reference Material
Salicylamide, puriss., >=99.0% (T)
Salicylamide, United States Pharmacopeia (USP) Reference Standard
Salicylamidum
Salicylamidum [INN-Latin]
Salicylic acid amide
Salipur
Salizell
Salizell (VAN)
Salrin
Salymid
Samid
SBB058584
SBI-0051509.P003
SC-46863
SCHEMBL21646
Serramida
SKZKKFZAGNVIMN-UHFFFAOYSA-N
SMR000046394
SPBio_001403
Spectrum_000946
SPECTRUM1500532
Spectrum2_001312
Spectrum3_000564
Spectrum4_000499
Spectrum5_001032
SR 4326
SR-01000721923
SR-01000721923-2
ST2410041
ST45061688
STK301812
Tox21_111129
Tox21_111129_1
Tox21_201944
Tox21_302801
TR-022279
TRA0035157
UNII-EM8BM710ZC
Urtosal
WLN: ZVR BQ
Z68590124
ZINC2055

US Patents and Regulatory Information for CETAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon CETAMIDE sulfacetamide sodium OINTMENT;OPHTHALMIC 080021-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Colorcon
McKinsey
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.